Dasatinib early intervention after cytogenetic or hematologic resistance to imatinib in patients with chronic myeloid leukemia
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference29 articles.
1. Chronic myeloid leukaemia as a model of disease evolution in human cancer;Melo;Nat Rev Cancer.,2007
2. Natural history and staging of chronic myelogenous leukemia;Cortes;Hematol Oncol Clin North Am.,2004
3. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med.,2006
4. Survival advantage from imatinib compared with the combination interferon-alpha plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between 2 phase 3 trials;Roy;Blood.,2006
5. Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia;Apperley;Lancet Oncol.,2007
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring;American Journal of Hematology;2024-08-02
2. Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics;Cancers;2024-01-24
3. Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring;American Journal of Hematology;2022-07-06
4. Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring;American Journal of Hematology;2020-04-10
5. Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study;Leukemia;2020-04-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3